Treatment of supraventricular tachycardias in the new millennium--drugs or radiofrequency catheter ablation?

Eur J Pediatr. 2001 Jan;160(1):1-9. doi: 10.1007/pl00008409.


Supraventricular tachycardias are a cause of significant morbidity in children. Newer anti-arrhythmic drugs and the invention of radiofrequency catheter ablation have revolutionised anti-arrhythmic therapy in children.

Conclusion: With the availability of these very effective therapeutic options, an improved knowledge of these methods and their indications is required.

Publication types

  • Review

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use*
  • Catheter Ablation*
  • Child
  • Humans
  • Tachycardia, Supraventricular / physiopathology
  • Tachycardia, Supraventricular / therapy*


  • Anti-Arrhythmia Agents